150 related articles for article (PubMed ID: 23809238)
1. Advanced precancerous lesions within the GI tract: the molecular background.
Fassan M; Baffa R; Kiss A
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):159-69. PubMed ID: 23809238
[TBL] [Abstract][Full Text] [Related]
2. miRNAs in precancerous lesions of the gastrointestinal tract.
Fassan M; Croce CM; Rugge M
World J Gastroenterol; 2011 Dec; 17(48):5231-9. PubMed ID: 22219591
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.
Tateishi K; Ohta M; Kanai F; Guleng B; Tanaka Y; Asaoka Y; Tada M; Seto M; Jazag A; Lianjie L; Okamoto M; Isayama H; Tada M; Yoshida H; Kawabe T; Omata M
Clin Cancer Res; 2006 Dec; 12(23):6960-6. PubMed ID: 17145814
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer.
Sui G; Zhou S; Wang J; Canto M; Lee EE; Eshleman JR; Montgomery EA; Sidransky D; Califano JA; Maitra A
Mol Cancer; 2006 Dec; 5():73. PubMed ID: 17166268
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular biology of pre-malignancy in the gastrointestinal tract.
Jass JR; Talbot IC
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):175-89. PubMed ID: 11355910
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets.
Zhang FF; Luo YH; Wang H; Zhao L
World J Gastroenterol; 2016 Oct; 22(39):8735-8749. PubMed ID: 27818589
[TBL] [Abstract][Full Text] [Related]
8. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
Malik UU; Zarina S; Pennington SR
Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker.
Zeng S; Xiao YF; Tang B; Hu CJ; Xie R; Yang SM; Li BS
Oncologist; 2015 Aug; 20(8):898-906. PubMed ID: 26156325
[TBL] [Abstract][Full Text] [Related]
10. Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects.
Craanen ME; Offerhaus GJ; Tytgat GN
Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):147-64. PubMed ID: 8995119
[TBL] [Abstract][Full Text] [Related]
11. Benign and malignant epithelial tumors of the gastroenteric tract. Chromosome analysis in study and diagnosis.
Messinetti S; Zelli GP; Marcellino LR; Alcini E
Cancer; 1968 May; 21(5):1000-10. PubMed ID: 5652765
[No Abstract] [Full Text] [Related]
12. Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases.
Jonaitis P; Kiudelis V; Streleckiene G; Gedgaudas R; Skieceviciene J; Kupcinskas J
Dig Dis; 2022; 40(1):1-13. PubMed ID: 33647906
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations in lymphomas of the gastrointestinal tract.
Barth TF; Döhner H; Möller P; Bentz M
Leuk Lymphoma; 1999 Dec; 36(1-2):25-32. PubMed ID: 10613447
[TBL] [Abstract][Full Text] [Related]
14. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.
Spoto CPE; Gullo I; Carneiro F; Montgomery EA; Brosens LAA
Semin Diagn Pathol; 2018 May; 35(3):170-183. PubMed ID: 29397239
[TBL] [Abstract][Full Text] [Related]
15. [Clinical perspective of precancerotic states in gastroenterology and their molecular genetics].
Mináriková P; Zavoral M
Vnitr Lek; 2010 Jan; 56(1):44-8. PubMed ID: 20184111
[TBL] [Abstract][Full Text] [Related]
16. Everything you always wanted to know about GIST (but were afraid to ask) An update on GIST pathology.
Ricci R; Saragoni L
Pathologica; 2016 Sep; 108(3):90-103. PubMed ID: 28195260
[TBL] [Abstract][Full Text] [Related]
17. Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy.
Huang Y; Deng X; Liang J
Int J Nanomedicine; 2019; 14():9469-9482. PubMed ID: 31819444
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.
Shigeyasu K; Toden S; Zumwalt TJ; Okugawa Y; Goel A
Clin Cancer Res; 2017 May; 23(10):2391-2399. PubMed ID: 28143873
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of dysplasia.
Zukerberg L
Semin Diagn Pathol; 2002 Feb; 19(1):48-53. PubMed ID: 11936266
[TBL] [Abstract][Full Text] [Related]
20. Use of genetic markers during endoscopic screening and follow-up of gastrointestinal precancerous lesions.
Van Laethem JL
Acta Gastroenterol Belg; 1995; 58(2):187-92. PubMed ID: 7571978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
